| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.9M | +88.5% | +116.1% |
| Cost of Revenue | $6.3M | +91.9% | +573.9% |
| Gross Profit | $629K | -11.9% | -72.1% |
| R&D Expense | $2.3M | -4.7% | +88.5% |
| SG&A Expense | $6.3M | -9.8% | +129.0% |
| Operating Income | -$8.7M | +7.5% | -410.9% |
| Net Income | -$7.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.6M | +0.1% | +2156.5% |
| Accounts Receivable | $3.0M | -23.6% | +10.2% |
| Inventory | $785K | +1.6% | +29.4% |
| Current Assets | $28.5M | -8.1% | +491.1% |
| Total Assets | $156.1M | +10.3% | +1163.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.0M | — | — |
| Capital Expenditures | $582K | — | — |
| Investing Cash Flow | -$85.5M | — | — |
| Financing Cash Flow | $107.3M | — | — |
| Free Cash Flow | -$31.6M | — | — |
| -185.7% |
| -248.0% |
| EPS (Basic) | -$0.17 | -177.3% | -1600.0% |
| EPS (Diluted) | -$0.17 | -177.3% | -1600.0% |
| $6.9M |
| +85.1% |
| +15.8% |
| Total Liabilities | $8.1M | +61.7% | +12.9% |
| Stockholders' Equity | $148.0M | +8.4% | +2759.6% |